BioPharma Drive: Drug Pricing

NOVEMBER 14, 2024

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.

Regulations 120

Regulations Drugs Marketing 120

Drug Patent Watch

NOVEMBER 19, 2024

The pharmaceutical industry is undergoing significant transformations, particularly in the realm of generic drug development. Recent trends and advancements in technology, research, and collaboration are reshaping the landscape of generic drug development, leading to new opportunities and challenges for pharmaceutical companies.

Drug Development 75

Drug Development Pharmaceutical Companies Drugs Pharmaceuticals 75

Broad Institute

OCTOBER 29, 2024

New drug triggers rapid cell death in cancer models By Karen Zusi-Tran October 29, 2024 Breadcrumb Home New drug triggers rapid cell death in cancer models BRD-810 inhibits the MCL1 protein and reactivates apoptosis in tumor cells, displaying therapeutic potential in animal models. The result was the compound named BRD-810.

Drugs 133

Drugs Small Molecule Pharmacokinetics Clinical Trials 133

Drug Patent Watch

NOVEMBER 7, 2024

The rising cost of prescription drugs has become a significant public health concern, with millions of Americans struggling to afford their medications. One crucial factor in mitigating this issue is the increased use of generic drugs.

Drugs 92

Drugs 92

BioPharma Drive: Drug Pricing

OCTOBER 17, 2024

Vyalev’s clearance is the second victory for AbbVie in Parkinson’s this year, following an April readout for a drug acquired through its Cerevel buyout.

Drugs 131

Drugs 131

Drug Patent Watch

NOVEMBER 14, 2024

CROs have become integral partners for drug developers, providing expertise and resources to navigate the challenges of drug development… Source

Drug Development 85

Drug Development Clinical Trials Drugs Pharmaceuticals 85

Collaborative Drug

SEPTEMBER 19, 2024

In a recent webinar, Janice Darlington from Collaborative Drug Discovery (CDD) with Tamsin Mansley from Optibrium discussed the importance of collaboration in drug discovery and showcased how their software platforms, CDD Vault and StarDrop , can enhance collaborative efforts.

Drugs 89

Drugs 89

BioPharma Drive: Drug Pricing

NOVEMBER 11, 2024

Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a better bet in buying Karuna Therapeutics.

Drugs 126

Drugs Marketing 126

Drug Patent Watch

OCTOBER 1, 2024

In the world of healthcare, few topics spark as much debate and confusion as prescription drug pricing. When it comes to prescription drug prices, we’re dealing with a… Source Have you ever wondered why that little pill in your medicine cabinet costs so much?

Drugs 104

Drugs Pharmaceuticals 104

Drug Patent Watch

NOVEMBER 18, 2024

The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S.

Drugs 68

Drugs Pharmaceuticals 68

Drug Patent Watch

OCTOBER 7, 2024

Pharmacokinetics (PK) plays a crucial role in the development and approval of generic drugs. PK studies help ensure that generic drugs are bioequivalent to their brand-name counterparts, meaning they have similar absorption, distribution, metabolism, and excretion (ADME) profiles.

Pharmacokinetics 100

Pharmacokinetics Drugs 100

BioPharma Drive: Drug Pricing

NOVEMBER 7, 2024

Now, Sarepta is abandoning a successor to its drug Exondys 51, citing an “evolving" treatment landscape. Elevidys sales have increased since the FDA made a controversial choice to expand the therapy's use.

Therapies 111

Therapies FDA Drugs Treatment 111

Drugs.com

SEPTEMBER 18, 2024

Food and Drug Administration's expanded approval of the treatment, drug maker Novartis. WEDNESDAY, Sept. 18, 2024 -- Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S.

FDA 116

FDA Drugs Treatment Disease 116

Drug Patent Watch

OCTOBER 16, 2024

Biosimilars, which are biologic drugs that are highly similar to an already approved biologic drug, are transforming the pharmaceutical industry. As patents for original biologic drugs expire, biosimilars are becoming increasingly important, offering more affordable treatment options for patients and healthcare systems.

Biosimilars 104

Biosimilars Drug Development Drugs Pharmaceuticals 104

The ChEMBL-og

OCTOBER 23, 2024

In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. This can be a roadblock for researchers who need that structural information to design effective drugs. BioChemGraph’s training material is now available! ->

Small Molecule 117

Small Molecule Drugs Research Science 117

BioPharma Drive: Drug Pricing

AUGUST 7, 2024

Executives at Amgen had few updates on their drug MariTide, but defended what they see as the once-monthly shot’s competitive profile.

FDA 120

FDA Drugs 120

Drug Patent Watch

NOVEMBER 20, 2024

Generic drug development is a complex process that involves rigorous scientific research and regulatory assessments. Food and Drug Administration (FDA) plays a crucial role in ensuring the quality and efficacy of generic drugs through various programs and guidelines.

Drug Development 52

Drug Development Science Drugs FDA 52

Drug Patent Watch

NOVEMBER 13, 2024

The generic drug industry faces significant challenges, including unstable economics, supply chain disruptions, and intense competition. To remain competitive and profitable, generic drug manufacturers must adopt innovative strategies to optimize their manufacturing processes.

Drugs 66

Drugs 66

BioPharma Drive: Drug Pricing

SEPTEMBER 8, 2024

Study results provide much-anticipated details to Summit’s claim earlier this year that its drug “decisively beat” Merck’s dominant immunotherapy.

Drugs 135

Drugs 135

Crown Bioscience

JUNE 6, 2024

In a significant development, the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023.

FDA Approval 105

FDA Approval FDA Drugs Research 105

Drug Patent Watch

OCTOBER 8, 2024

A recent study published in Drug Discovery Today highlights the potential of artificial intelligence (AI) in revolutionizing drug discovery and development processes[1].

Clinical Trials 104

Clinical Trials Drugs Pharmaceuticals Trials 104

Drug Patent Watch

OCTOBER 21, 2024

The filing of drug patents in emerging markets is a critical aspect of this protection, as it ensures that companies can recoup their investments and… Source The pharmaceutical industry is a significant contributor to the global economy, with a substantial portion of its production costs incurred during the development stage.

Marketing 94

Marketing Drugs Pharmaceuticals Production 94

Common Sense for Drug Policy Blog

NOVEMBER 15, 2024

Misrepresentation of Drugs in the Unregulated Market "The misrepresentation of illicit drugs is a persistent problem in unregulated markets ( Barratt et al., When users consume illicit drugs of unknown content, quality, and dosage, their risk of overdose and other adverse health events increases significantly ( Singh et al.,

Marketing 52

Marketing Drugs 52

Drug Patent Watch

SEPTEMBER 30, 2024

Patent expirations have a significant impact on the pharmaceutical industry, particularly on the generic drug market. When a drug’s patent expires, other manufacturers can produce and market generic versions of the drug, leading to increased competition and lower prices.

Marketing 100

Marketing Drugs Pharmaceuticals 100

Drug Patent Watch

OCTOBER 1, 2024

The answer often lies in the complex world of drug patents. Let’s dive into the fascinating realm of pharmaceutical intellectual property and explore when drug patents expire. Drug patents are a crucial aspect of the pharmaceutical industry. They provide companies with exclusive… Source

Pharmaceuticals 111

Pharmaceuticals Drugs 111

BioPharma Drive: Drug Pricing

NOVEMBER 1, 2024

The Phase 3 findings position semaglutide to become the first drug of its kind for the liver disease. But they also confirm GLP-1s aren't a "silver bullet" for MASH, one analyst argued.

Drugs 117

Drugs Disease 117

Drugs.com

SEPTEMBER 20, 2024

20, 2024 -- Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced.Known as TIRF medications, these products contain fentanyl and are used to. FRIDAY, Sept.

FDA 110

FDA Drugs Production 110

Collaborative Drug

AUGUST 28, 2024

Nanome and Collaborative Drug Discovery (CDD) are excited to announce a partnership that streamlines cheminformatic workflows for drug discovery Together, Nanome and Collaborative Drug Discovery (CDD) are committed to enhancing the efficiency and innovation of drug discovery teams by providing an integrated solution for molecular visualization, design, (..)

Drugs 87

Drugs 87

Drug Patent Watch

OCTOBER 24, 2024

The generic drug industry faces significant regulatory challenges that can impact the quality and safety of these life-saving medications. With the majority of generic drugs manufactured overseas, ensuring compliance with regulatory standards is crucial. Food and Drug Administration… Source

Compliance 76

Compliance Drugs Regulations 76

Science Daily: Pharmacology News

JULY 25, 2024

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.

Virus 141

Virus Drugs Treatment 141

DrugBank

JUNE 27, 2024

Drug repurposing is an approach that, while not new, has become popular in the last decade.   One of the most exciting prospects of drug repurposing is its potential to tackle "undruggable" targets—proteins or molecules that traditional drugs can't easily bind to.

Drugs 72

Drugs Pharma Companies Clinical Trials Computational Chemistry 72

Drug Patent Watch

NOVEMBER 6, 2024

Developing a Risk Management Plan (RMP) for generic drugs is a crucial step in ensuring the safety and efficacy of these medications. Here is a comprehensive guide on how to develop an RMP for generic drugs: Developing a… Source

Drugs 85

Drugs Drug Development 85

Drug Patent Watch

OCTOBER 3, 2024

Humira, used to treat various autoimmune diseases, has become the world’s best-selling drug. AbbVie has fiercely protected its patent through a strategy known as “patent thickets,” filing over 100 additional patents related to the drug’s manufacturing process, formulation, and methods of treatment[1].

Drugs 93

Drugs Treatment Disease 93

Drug Patent Watch

NOVEMBER 18, 2024

This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs. The future of generic drug development in emerging markets looks promising, with technological advancements… Source

Drug Development 59

Drug Development Marketing Drugs Pharmaceuticals 59

Drugs.com

OCTOBER 28, 2024

28, 2024 -- An experimental electric bandage might help doctors stop bacterial infections without using any drugs, a new study suggests.Imperceptible low-level electric current applied through a skin patch caused a nearly 10 times. MONDAY, Oct.

Doctors 111

Doctors Drugs 111

Drug Patent Watch

OCTOBER 14, 2024

Risk assessment plays a crucial role in the development of generic drugs, ensuring that these products meet the required standards of safety and efficacy.

Drug Development 97

Drug Development Drugs FDA Production 97

Drug Patent Watch

SEPTEMBER 26, 2024

The generic drug market is a complex and dynamic environment where multiple factors influence the availability, quality, and pricing of generic drugs. Conducting an effective market analysis is crucial for pharmaceutical companies, policymakers, and healthcare professionals to understand the market dynamics and make informed decisions.

Marketing 100

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 100